Protagonist Therapeutics, Inc.
CONJUGATED HEPCIDIN MIMETICS
Last updated:
Abstract:
The present invention provides hepcidin analogues with improved in vivo half lives, and related pharmaceutical compositions and methods of use thereof.
Status:
Application
Type:
Utility
Filling date:
8 Feb 2019
Issue date:
19 Nov 2020